Global Benign Prostatic Hyperplasia Testing Market Research Report 2023

Benign prostatic hyperplasia (BPH) is a condition occurring in men when the prostate gland is enlarged. Benign prostatic hyperplasia is also termed as benign prostatic hypertrophy or benign prostatic obstruction. Prostate gland grows in primarily two phases, firstly during puberty when the size of the prostate doubles and the second growth phase starts at 25 years and continues throughout the lifetime. While the prostate gland enlarges in a man, it presses and pinches the urethra making the bladder wall thick. This pressure and squeeze on the urethra weaken the bladder and makes it lose the ability to empty the urine completely. Urinary retention and narrowing of the urethra can cause many problems which are associated with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the common prostate problems for men older than age 50.

The global Benign Prostatic Hyperplasia Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Benign prostatic hyperplasia testing market is primarily driven by a few key factors such as the growing geriatric male population, patient awareness regarding rising healthcare concerns, increase in healthcare expenditure, increasing government initiatives and availability of minimally invasive surgery as a drug replacement, faster and easy performing diagnosis test results. The market is likely to grow owing to the novel diagnostic methods which are accurate than the conventional PSA blood test for benign prostatic hyperplasia which is effective in diagnosis and is expected to fuel the growth of benign prostatic hyperplasia testing market.

This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hyperplasia Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hyperplasia Testing.

The Benign Prostatic Hyperplasia Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Benign Prostatic Hyperplasia Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Benign Prostatic Hyperplasia Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Urinalysis

1.2.3 Prostate-Specific Antigen (PSA) Blood Test

1.2.4 Urodynamic Test

1.2.5 Cystoscopy

1.3 Market by Application

1.3.1 Global Benign Prostatic Hyperplasia Testing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Clinics

1.3.5 Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Benign Prostatic Hyperplasia Testing Market Perspective (2018-2029)

2.2 Benign Prostatic Hyperplasia Testing Growth Trends by Region

2.2.1 Global Benign Prostatic Hyperplasia Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Benign Prostatic Hyperplasia Testing Historic Market Size by Region (2018-2023)

2.2.3 Benign Prostatic Hyperplasia Testing Forecasted Market Size by Region (2024-2029)

2.3 Benign Prostatic Hyperplasia Testing Market Dynamics

2.3.1 Benign Prostatic Hyperplasia Testing Industry Trends

2.3.2 Benign Prostatic Hyperplasia Testing Market Drivers

2.3.3 Benign Prostatic Hyperplasia Testing Market Challenges

2.3.4 Benign Prostatic Hyperplasia Testing Market Restraints

3.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue

3.1.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue (2018-2023)

3.1.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Players (2018-2023)

3.2 Global Benign Prostatic Hyperplasia Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Testing Revenue

3.4 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio

3.4.1 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Testing Revenue in 2022

3.5 Benign Prostatic Hyperplasia Testing Key Players Head office and Area Served

3.6 Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service

3.7 Date of Enter into Benign Prostatic Hyperplasia Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Type (2018-2023)

4.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2024-2029)

5.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Application (2018-2023)

5.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2024-2029)

6.1 North America Benign Prostatic Hyperplasia Testing Market Size (2018-2029)

6.2 North America Benign Prostatic Hyperplasia Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023)

6.4 North America Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Benign Prostatic Hyperplasia Testing Market Size (2018-2029)

7.2 Europe Benign Prostatic Hyperplasia Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023)

7.4 Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size (2018-2029)

8.2 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2018-2023)

8.4 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Benign Prostatic Hyperplasia Testing Market Size (2018-2029)

9.2 Latin America Benign Prostatic Hyperplasia Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023)

9.4 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size (2018-2029)

10.2 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023)

10.4 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AEternaZentaris

11.1.1 AEternaZentaris Company Detail

11.1.2 AEternaZentaris Business Overview

11.1.3 AEternaZentaris Benign Prostatic Hyperplasia Testing Introduction

11.1.4 AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.1.5 AEternaZentaris Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Detail

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Benign Prostatic Hyperplasia Testing Introduction

11.2.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.2.5 Astellas Pharma Recent Development

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Detail

11.3.2 Eli Lilly and Company Business Overview

11.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Introduction

11.3.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.3.5 Eli Lilly and Company Recent Development

11.4 IntelGenx Technologies Corp

11.4.1 IntelGenx Technologies Corp Company Detail

11.4.2 IntelGenx Technologies Corp Business Overview

11.4.3 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Introduction

11.4.4 IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.4.5 IntelGenx Technologies Corp Recent Development

11.5 Nymox Pharmaceutical Corporation

11.5.1 Nymox Pharmaceutical Corporation Company Detail

11.5.2 Nymox Pharmaceutical Corporation Business Overview

11.5.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Introduction

11.5.4 Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.5.5 Nymox Pharmaceutical Corporation Recent Development

11.6 Protox Therapeutics

11.6.1 Protox Therapeutics Company Detail

11.6.2 Protox Therapeutics Business Overview

11.6.3 Protox Therapeutics Benign Prostatic Hyperplasia Testing Introduction

11.6.4 Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.6.5 Protox Therapeutics Recent Development

11.7 Quest PharmaTech

11.7.1 Quest PharmaTech Company Detail

11.7.2 Quest PharmaTech Business Overview

11.7.3 Quest PharmaTech Benign Prostatic Hyperplasia Testing Introduction

11.7.4 Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023)

11.7.5 Quest PharmaTech Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Urinalysis

    Table 3. Key Players of Prostate-Specific Antigen (PSA) Blood Test

    Table 4. Key Players of Urodynamic Test

    Table 5. Key Players of Cystoscopy

    Table 6. Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Benign Prostatic Hyperplasia Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Benign Prostatic Hyperplasia Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Benign Prostatic Hyperplasia Testing Market Share by Region (2018-2023)

    Table 10. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Benign Prostatic Hyperplasia Testing Market Share by Region (2024-2029)

    Table 12. Benign Prostatic Hyperplasia Testing Market Trends

    Table 13. Benign Prostatic Hyperplasia Testing Market Drivers

    Table 14. Benign Prostatic Hyperplasia Testing Market Challenges

    Table 15. Benign Prostatic Hyperplasia Testing Market Restraints

    Table 16. Global Benign Prostatic Hyperplasia Testing Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Benign Prostatic Hyperplasia Testing Market Share by Players (2018-2023)

    Table 18. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2022)

    Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Testing Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Testing Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service

    Table 23. Date of Enter into Benign Prostatic Hyperplasia Testing Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Benign Prostatic Hyperplasia Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2018-2023)

    Table 27. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2024-2029)

    Table 29. Global Benign Prostatic Hyperplasia Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2018-2023)

    Table 31. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2024-2029)

    Table 33. North America Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 48. AEternaZentaris Company Detail

    Table 49. AEternaZentaris Business Overview

    Table 50. AEternaZentaris Benign Prostatic Hyperplasia Testing Product

    Table 51. AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 52. AEternaZentaris Recent Development

    Table 53. Astellas Pharma Company Detail

    Table 54. Astellas Pharma Business Overview

    Table 55. Astellas Pharma Benign Prostatic Hyperplasia Testing Product

    Table 56. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 57. Astellas Pharma Recent Development

    Table 58. Eli Lilly and Company Company Detail

    Table 59. Eli Lilly and Company Business Overview

    Table 60. Eli Lilly and Company Benign Prostatic Hyperplasia Testing Product

    Table 61. Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 62. Eli Lilly and Company Recent Development

    Table 63. IntelGenx Technologies Corp Company Detail

    Table 64. IntelGenx Technologies Corp Business Overview

    Table 65. IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Product

    Table 66. IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 67. IntelGenx Technologies Corp Recent Development

    Table 68. Nymox Pharmaceutical Corporation Company Detail

    Table 69. Nymox Pharmaceutical Corporation Business Overview

    Table 70. Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Product

    Table 71. Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 72. Nymox Pharmaceutical Corporation Recent Development

    Table 73. Protox Therapeutics Company Detail

    Table 74. Protox Therapeutics Business Overview

    Table 75. Protox Therapeutics Benign Prostatic Hyperplasia Testing Product

    Table 76. Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 77. Protox Therapeutics Recent Development

    Table 78. Quest PharmaTech Company Detail

    Table 79. Quest PharmaTech Business Overview

    Table 80. Quest PharmaTech Benign Prostatic Hyperplasia Testing Product

    Table 81. Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2018-2023) & (US$ Million)

    Table 82. Quest PharmaTech Recent Development

    Table 83. Research Programs/Design for This Report

    Table 84. Key Data Information from Secondary Sources

    Table 85. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Benign Prostatic Hyperplasia Testing Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Benign Prostatic Hyperplasia Testing Market Share by Type: 2022 VS 2029

    Figure 3. Urinalysis Features

    Figure 4. Prostate-Specific Antigen (PSA) Blood Test Features

    Figure 5. Urodynamic Test Features

    Figure 6. Cystoscopy Features

    Figure 7. Global Benign Prostatic Hyperplasia Testing Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Diagnostic Centers Case Studies

    Figure 11. Clinics Case Studies

    Figure 12. Research Institutes Case Studies

    Figure 13. Benign Prostatic Hyperplasia Testing Report Years Considered

    Figure 14. Global Benign Prostatic Hyperplasia Testing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Benign Prostatic Hyperplasia Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Benign Prostatic Hyperplasia Testing Market Share by Region: 2022 VS 2029

    Figure 17. Global Benign Prostatic Hyperplasia Testing Market Share by Players in 2022

    Figure 18. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Testing Revenue in 2022

    Figure 20. North America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Benign Prostatic Hyperplasia Testing Market Share by Country (2018-2029)

    Figure 22. United States Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Benign Prostatic Hyperplasia Testing Market Share by Country (2018-2029)

    Figure 26. Germany Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Share by Region (2018-2029)

    Figure 34. China Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Benign Prostatic Hyperplasia Testing Market Share by Country (2018-2029)

    Figure 42. Mexico Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Share by Country (2018-2029)

    Figure 46. Turkey Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. AEternaZentaris Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 49. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 50. Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 51. IntelGenx Technologies Corp Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 52. Nymox Pharmaceutical Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 53. Protox Therapeutics Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 54. Quest PharmaTech Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed